These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 34079630)

  • 1. Cutaneous methotrexate-related T-cell lymphoproliferative disorder with CD4, CD30, CD56, EBV-positive tumor cell infiltration: a case illustration and a brief review.
    Omori I; Kawanabe R; Hashimoto Y; Mitsui A; Kodama K; Nogi S; Tsuno H; Horita A; Saito I; Ohmatsu H
    Am J Blood Res; 2021; 11(2):163-167. PubMed ID: 34079630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
    Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Ogata M; Daa T; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
    BMC Cancer; 2022 Dec; 22(1):1342. PubMed ID: 36544095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful Treatment of Intracranial Methotrexate-associated Lymphoproliferative Disorder without Epstein-Barr Virus Infection Using Rituximab, Methotrexate, Procarbazine, and Vincristine: A Case Report.
    Mizushima M; Ishi Y; Ikeda H; Echizenya I; Otsuka T; Mitsuhashi T; Yamaguchi S; Fujimura M
    NMC Case Rep J; 2022; 9():237-242. PubMed ID: 36061907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
    Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K
    Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
    Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
    Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cessation of methotrexate and a small intestinal resection provide a good clinical course for a patient with a jejunum perforation induced by a methotrexate-associated lymphoproliferative disorder: a case report.
    Nomura M; Sumiya R; Ono H; Nagai T; Kumazawa K; Shimizu A; Endo D; Aoyanagi N
    World J Surg Oncol; 2021 Jan; 19(1):4. PubMed ID: 33388058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-associated primary cutaneous CD30-positive cutaneous T-cell lymphoproliferative disorder: a case illustration and a brief review.
    Claudino WM; Gibson B; Tse W; Krem M; Grewal J
    Am J Blood Res; 2016; 6(1):1-5. PubMed ID: 27335685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous regression of breast lymphoproliferative disorders after withdrawal of methotrexate in rheumatoid arthritis patients with Epstein-Barr virus infection: a case report and review of the literature.
    Ogawa A; Nakagawa T; Kumaki Y; Hosoya T; Oda G; Mori M; Fujioka T; Kubota K; Onishi I; Uetake H
    J Med Case Rep; 2022 Feb; 16(1):49. PubMed ID: 35125110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: A case report.
    Omameuda T; Miyato H; Sata N; Lefor AK
    Medicine (Baltimore); 2022 Nov; 101(47):e31993. PubMed ID: 36451467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin-Limited, Methotrexate-Associated Epstein-Barr Virus-Positive Mucocutaneous Ulcer-A Mimicker of High-Grade Lymphoma. A Report of 4 Cases and Review of the Literature.
    Macklin PS; Fisher R; Stonard C; Matin RN; Ieremia E
    Am J Dermatopathol; 2023 Aug; 45(8):519-531. PubMed ID: 37462204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphoproliferative disorder with pathological fracture of the femur in a patient with rheumatoid arthritis treated with methotrexate: A case report.
    Oebisu N; Hoshi M; Ieguchi M; Iwai T; Tanaka S; Osawa M; Nakamura H
    Mol Clin Oncol; 2018 Aug; 9(2):187-191. PubMed ID: 30101019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methotrexate-associated orbital lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.
    Kobayashi Y; Kimura K; Fujitsu Y; Shinkawa K; Muta H; Sonoda KH
    Jpn J Ophthalmol; 2016 May; 60(3):212-8. PubMed ID: 27018050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-infected subcutaneous panniculitis-like T-cell lymphoma associated with methotrexate treatment.
    Nemoto Y; Taniguchi A; Kamioka M; Nakaoka Y; Hiroi M; Yokoyama A; Enzan H; Daibata M
    Int J Hematol; 2010 Sep; 92(2):364-8. PubMed ID: 20665252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders.
    Kakiuchi S; Yakushijin K; Takagi I; Rikitake J; Akiyama H; Matsuba H; Hayashi Y; Kajimoto K; Iwata N
    Front Med (Lausanne); 2020; 7():625442. PubMed ID: 33425968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-positive CD30+ B-cell lymphoproliferative disease with histologic features resembling grade III lymphomatoid granulomatosis induced by methotrexate.
    Quaye EH; D'Angelis C; Powell J
    Dermatol Online J; 2023 Feb; 29(1):. PubMed ID: 37040909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Case of Methotrexate-Associated Lymphoproliferative Disorder (Lymphomatoid Granulomatosis) of the Skin.
    Nishida H; Oyama Y; Kusaba T; Kadowaki H; Arakane M; Yokoyama S; Hatano Y; Daa T
    Am J Dermatopathol; 2019 Jun; 41(6):448-452. PubMed ID: 31112139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial Methotrexate-Associated Lymphoproliferative Disorder in Rheumatoid Arthritis.
    Miyaza S; Matsuda R; Nakamura M; Nakagawa I; Motoyama Y; Nakase H
    World Neurosurg; 2019 Oct; 130():138-141. PubMed ID: 31295614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Methotrexate-Related Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma in a Patient with Granulomatous Cutaneous T-Cell Lymphoma: A Case Report and Literature Review.
    Kositkuljorn C; Rutnin S; Rattananukrom T; Puavilai T; Khiankaew B; Boonsakan P; Iamsumang W
    Clin Cosmet Investig Dermatol; 2023; 16():2229-2235. PubMed ID: 37601419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary Adrenal Lymphoma Possibly Associated With Epstein-Barr Virus Reactivation Due to Immunosuppression Under Methotrexate Therapy.
    Ohkura Y; Shindoh J; Haruta S; Kaji D; Ota Y; Fujii T; Hashimoto M; Watanabe G; Matsuda M
    Medicine (Baltimore); 2015 Aug; 94(31):e1270. PubMed ID: 26252293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of Epstein-Barr virus in the development and spontaneous regression of methotrexate-associated lymphoproliferative disorder in patients with rheumatoid arthritis.
    Kitamura N; Sugiyama K; Nagasawa Y; Hamaguchi M; Kobayashi H; Takei M
    Clin Exp Rheumatol; 2022 Jul; 40(7):1330-1335. PubMed ID: 34369356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.